Interstitial Cystitis/BPS
Interstitial Cystitis (IC), often referred to as painful bladder syndrome (BPS), is a chronic condition characterized by bladder pain, urinary urgency, frequency, and pelvic discomfort. Many patients are told that IC has no clear cause and that treatment options are limited to symptom management. I personally have struggled with this condition and would not accept this response. Having a provider who knows what it is like to struggle with the same disorder as you is a special experience, and I completely understand what this is like. Addressing IC/BPS with a functional medicine approach focuses on identifying and addressing the underlying drivers of bladder inflammation. I consider how infections, immune dysfunction, inflammation, microbiome imbalance, methylation, mast cells and environmental exposures may contribute to this condition. This approach seeks to understand why the bladder is inflamed rather than simply suppressing symptoms.
Breaking it down
A provider who has completely revolutionized the treatment of IC/BPS is Ruth Kriz, a nurse practitioner who studied complex urinary tract infections and interstitial cystitis for many years. Her work suggests that persistent bladder symptoms may sometimes be related to embedded infections, biofilms, and multiple contributing biological factors. Embedded Infections and chronic bladder symptoms are often failed by standard urine cultures used in many medical settings as they often fail to detect certain organisms. In some patients with persistent bladder symptoms, microbes may exist within bladder tissues or protective microbial communities called biofilms, which can make them difficult to detect and treat. Because of this limitation, I utilize advanced molecular diagnostics from MicroGenDX. This testing uses next-generation DNA sequencing to identify bacterial and fungal organisms that may not grow on traditional cultures. In certain cases, this technology may reveal polymicrobial infections or organisms contributing to ongoing bladder inflammation. Identifying these organisms helps to guide targeted treatment strategies and provide insight into possible drivers of persistent symptoms.
Biofilms: Why Some Infections Persist
Biofilms are protective structures created by microorganisms that allow them to survive in hostile environments. Within these structures, bacteria can hide from antibiotics and the immune system, making infections more difficult to eradicate. In chronic bladder conditions, biofilms may allow multiple microbes to coexist within the urinary tract. Over time, different organisms may become dominant, which can change the pattern of symptoms experienced by the patient. Because of this, treatment strategies may sometimes involve targeting dominant organisms while addressing the protective biofilms.
Targeted Antimicrobial Treatment
When testing identifies specific pathogens, treatment may involve targeted antimicrobial therapy. In some cases, this may include carefully selected antibiotics or antifungals guided by susceptibility data. Rather than relying on a single universal treatment, therapies may be individualized based on the organisms detected and the patient’s overall clinical picture.Treatment approaches can evolve over time as the microbial environment shifts or as additional organisms emerge from biofilms.
Urine pH and Bladder Irritation
Urine chemistry can also influence bladder symptoms. Strategies that may help support a more comfortable urinary environment include: maintaining adequate hydration, monitoring urine pH, adjusting dietary triggers, supporting the body and calming the immune system. Although pH management alone is rarely sufficient to resolve symptoms, it may reduce irritation and support comfort while deeper causes are addressed.
Supporting the Bladder’s Protective Lining
The bladder is protected by a specialized mucosal barrier often referred to as the glycosaminoglycan (GAG) layer. This layer helps prevent irritating compounds in urine from penetrating deeper tissues. Chronic inflammation, infections, and certain metabolic byproducts can damage this protective barrier. When the bladder lining becomes compromised, the tissue may become more sensitive to irritation. It is important to support the body so that the bladder lining can heal.
Looking at the Whole Person
Interstitial cystitis is rarely caused by a single factor. A comprehensive evaluation may consider multiple contributors, including: chronic infections, immune system dysregulation, genetic factors affecting detoxification or inflammation, nutrient deficiencie, senvironmental exposures, and gut microbiome health to name a few. By addressing these interconnected systems, functional medicine aims to support the body’s ability to restore balance and reduce chronic inflammation.
A Personalized Approach to IC
Because every patient’s biology and history are unique, treatment plans should be individualized. A root-cause approach may include detailed health history, dietary evaluation, advanced testing, and a careful review of environmental and lifestyle factors. This broader perspective can uncover contributing factors that may have been overlooked in conventional treatment models.
When to Seek Care
If you are experiencing symptoms that have been difficult to treat and are interested in the approach I offer, don’t hesitate to call. There are no symptoms that are too small to seek treatment, if you feel that your body needs support it does.
